Tyrosine kinase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C540S472000

Reexamination Certificate

active

07371754

ABSTRACT:
The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases. The compounds of the instant invention possess a core structure that comprises a benzazocine moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds.

REFERENCES:
patent: 4332810 (1982-06-01), Belanger et al.
patent: WO 02/24692 (2002-03-01), None
patent: WO 03 086314 (2003-10-01), None
patent: WO 03 086395 (2003-10-01), None
Khandwala et al. Endocrine Reviews, 2000, 21(3), 215-244.
“What is Cancer / General Definition of Cancer”. http://training.seer.cancer.gov/module—cancer—disease/units—whatiscancer1—definition.html, accessed Jul. 12, 2007.
Paradisi et al. Tetrahedron Asymmetry, 2000, 11 (22), 4617-4622.(based on HCAPlus abstract).
Amirkhosravi et al. Platelets, 1999, 10, 285-292.
Midgley et al. Expert Opinion in Investigational Drugs, 2001, 10(6), 1011-1019.
Paradisi et al. Tetrahedron: asymmetry, 2000, 11, 4617-22.
Belanger, et al., Can. J. Chem., vol. 61, pp. 2177-2182, 1993.
Iddon, et al., J. Chem. Soc. Perkin Trans., vol. 4, pp. 1083-1090, 1990.
Workman, et al., Seminars in Cancer Biology, vol. 3, pp. 369-381, 1992.
Belanger, et al., J. Org. Chem., vol. 47, pp. 4329-4334, 1982.
Paradisi, et al., Tetrahedron: Asymmetry, vol. 11, pp. 4617-4622, 2000.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosine kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2764636

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.